Enzo Biochem Inc
ENZBDelisted Apr 7, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Enzo Biochem Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q2 2023
- Shares held
- 16.5M
- −2.30M (−12.2%) vs. Q2 2023
- Total value
- $23.1M
- −$11.5M (−33.2%) vs. Q2 2023
- New holders
- 4
- 7 more added
- Sold out
- 11
- 9 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 7 | $2.00M |
| Q1 2025 | 41 | $4.96M |
| Q4 2024 | 44 | $9.71M |
| Q3 2024 | 43 | $14.2M |
| Q2 2024 | 39 | $13.5M |
| Q1 2024 | 41 | $17.6M |
| Q4 2023 | 46 | $22.7M |
| Q3 2023 | 39 | $23.1M |
| Q2 2023 | 47 | $34.7M |
| Q1 2023 | 52 | $48.1M |
| Q4 2022 | 52 | $26.8M |
| Q3 2022 | 49 | $45.6M |
| Q2 2022 | 54 | $43.8M |
| Q1 2022 | 51 | $62.0M |
| Q4 2021 | 59 | $69.0M |
| Q3 2021 | 65 | $82.9M |
| Q2 2021 | 72 | $76.6M |
| Q1 2021 | 82 | $94.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Benjamin Edwards Inc | 300 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 10 | $14 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 110 | $154 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 300 | $420 | 0.00% | +300 | New |
| Royal Bank of Canada | 1,085 | $1.00K | 0.00% | −97−8.2% | Reduced |
| Wells Fargo & Company | 1,282 | $1.80K | 0.00% | +7+0.5% | Added |
| Advisor Group Holdings, Inc. | 1,731 | $2.42K | 0.00% | +728+72.6% | Added |
| JPMorgan Chase & Co | 1,833 | $2.57K | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 2,525 | $3.00K | 0.00% | +2,525 | New |
| Bank of America Corp | 3,088 | $4.32K | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 3,967 | $6.00K | 0.00% | +3,967 | New |
| Citadel Advisors LLC | 7,334 | $10.3K | 0.00% | +1,288+21.3% | Added |
| Charles Schwab Investment Management Inc | 13,471 | $18.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,453 | $21.6K | 0.00% | +5,544+55.9% | Added |
| Shulman DeMeo Asset Management LLC | 15,487 | $21.7K | 0.01% | 00.0% | Unchanged |
| Raymond James Trust N.A. | 17,016 | $23.8K | 0.00% | 00.0% | Unchanged |
| Paradigm Financial Partners, LLC | 19,500 | $26.3K | 0.01% | 00.0% | Unchanged |
| AE Wealth Management LLC | 20,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Snowden Capital Advisors LLC | 21,499 | $30.1K | 0.00% | −1,200−5.3% | Reduced |
| Sage Mountain Advisors LLC | 23,362 | $32.7K | 0.00% | 00.0% | Unchanged |
| Kempner Capital Management Inc. | 25,475 | $36.0K | 0.02% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,217 | $36.7K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 44,800 | $63.0K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 50,453 | $70.0K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 62,500 | $87.5K | 0.03% | +62,500 | New |
| Morgan Stanley | 75,639 | $105.9K | 0.00% | +8,000+11.8% | Added |
| Assenagon Asset Management S.A. | 81,197 | $113.7K | 0.00% | −100,665−55.4% | Reduced |
| Northern Trust Corp | 104,181 | $145.9K | 0.00% | −399−0.4% | Reduced |
| State Street Corp | 167,039 | $233.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 227,100 | $317.9K | 0.01% | −82,299−26.6% | Reduced |
| RBF Capital, LLC | 250,359 | $350.5K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 337,856 | $473.1K | 0.00% | +281+0.1% | Added |
| Dimensional Fund Advisors LP | 843,086 | $1.18M | 0.00% | −423,989−33.5% | Reduced |
| BlackRock Inc. | 955,394 | $1.34M | 0.00% | −43,085−4.3% | Reduced |
| Potomac Capital Management, Inc. | 1,455,000 | $2.04M | 2.62% | +405,100+38.6% | Added |
| Vanguard Group Inc | 1,729,084 | $2.42M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 2,200,000 | $3.08M | 0.43% | −100,000−4.3% | Reduced |
| Renaissance Technologies LLC | 2,556,064 | $3.58M | 0.01% | −148,800−5.5% | Reduced |
| Harbert Fund Advisors, Inc. | 5,175,913 | $7.25M | 5.17% | 00.0% | Unchanged |
| Fuller & Thaler Asset Management, Inc. | 0 | $0 | 0.00% | −985,660−100.0% | Sold out |
| Roumell Asset Management, LLC | 0 | $0 | 0.00% | −681,358−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −47,726−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −19,610−100.0% | Sold out |
| Agate Pass Investment Management, LLC | 0 | $0 | 0.00% | −16,292−100.0% | Sold out |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,534−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −11,705−100.0% | Sold out |
| Wealth Alliance | 0 | $0 | 0.00% | −11,033−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −619−100.0% | Sold out |
| BDO Wealth Advisors, LLC | – | – | – | – | Not filed |